Concepedia

Publication | Open Access

Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology

22

Citations

9

References

2019

Year

Abstract

This study demonstrates that the tofacitinib ECS osmotic tablet platform can achieve a Level A IVIVC, similar to other osmotic delivery systems.

References

YearCitations

Page 1